Nephros Inc (NEPH): Revenue
$18.79M
Year ended 2025-12-31
$20.72M
Trailing 12 months to 2026-06-30
+23.5%
3-year compound annual growth
| Period ended | Revenue | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $18.79M | +32.7% | 2026-03-12, From 2025-01-01 |
| 2024-12-31 | $14.16M | -0.5% | 2026-03-12, From 2024-01-01 |
| 2023-12-31 | $14.24M | +42.7% | 2025-03-24, From 2023-01-01 |
| 2022-12-31 | $9.97M | -2.4% | 2024-03-15, From 2022-01-01 |
| 2021-12-31 | $10.22M | n/c | 2023-03-23, From 2021-01-01 |
| 2020-12-31 | $8.56M | -17.2% | 2022-03-03, From 2020-01-01 |
| 2019-12-31 | $10.33M | +81.7% | 2021-03-01, From 2019-01-01 |
| 2018-12-31 | $5.69M | +49.3% | 2020-02-27, From 2018-01-01 |
| 2017-12-31 | $3.81M | +64.2% | 2019-03-12, From 2017-01-01 |
| 2016-12-31 | $2.32M | +19.3% | 2018-02-26, From 2016-01-01 |
| 2015-12-31 | $1.94M | +11.2% | 2017-03-20, From 2015-01-01 |
| 2014-12-31 | $1.75M | +0.5% | 2016-03-30, From 2014-01-01 |
| 2013-12-31 | $1.74M | -3.7% | 2015-04-15, From 2013-01-01 |
| 2012-12-31 | $1.81M | -18.4% | 2014-03-28, From 2012-01-01 |
| 2011-12-31 | $2.21M | -24.6% | 2013-03-04, From 2011-01-01 |
| 2010-12-31 | $2.94M | n/a | 2012-03-22, From 2010-01-01 |
Revenue at similar companies
| Company | Year ended | Revenue | Change YoY |
|---|---|---|---|
| Nephros Inc (NEPH) | 2025-12-31 | $18.79M | +32.7% |
| Sonoma Pharmaceuticals, Inc. (SNOA) | 2026-03-31 | $19.53M | +36.7% |
| Spectral AI, Inc. (MDAI) | 2025-12-31 | $19.65M | -33.6% |
| Vivos Therapeutics, Inc. (VVOS) | 2025-12-31 | $17.44M | +16.0% |
| Profound Medical Corp. (PROF) | 2025-12-31 | $16.10M | +50.7% |
| Biotricity Inc. (BTCY) | 2026-03-31 | $16.00M | +16.0% |
| DarioHealth Corp. (DRIO) | 2025-12-31 | $22.36M | -17.3% |
| Baird Medical Investment Holdings Ltd (BDMD) | 2025-12-31 | $22.54M | -39.2% |
| Allurion Technologies, Inc. (ALUR) | 2025-12-31 | $15.23M | -52.6% |
Compare NEPH, SNOA, MDAI, VVOS side by side · Screen every company in Surgical & Medical Instruments & Apparatus ↗